This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Ab. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Erifili Masialou: Innovator in Coagulation Research
Introduction
Erifili Masialou is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of coagulation research, particularly through her innovative work on modified coagulation agents. Her dedication to advancing scientific knowledge is evident in her patent portfolio.
Latest Patents
Erifili holds a patent for a modified coagulation factor Xa. This invention is directed towards a modified coagulation factor Xa that exhibits an improved capacity for forming crystals compared to its native form. Such crystals or crystalline compositions are particularly useful for studies involving the crystalline form of the active catalytic site of factor Xa when complexed with a specific affinity ligand that possesses inhibiting characteristics.
Career Highlights
Erifili Masialou is currently employed at Pharmacia & Upjohn AB, where she continues to push the boundaries of coagulation research. Her work has garnered attention for its potential applications in medical and scientific fields.
Collaborations
Throughout her career, Erifili has collaborated with notable colleagues, including Joanna Chmielewska and Tomas Lundqvist. These partnerships have enriched her research and contributed to the advancement of their shared goals in the field.
Conclusion
Erifili Masialou's innovative work in the area of coagulation research exemplifies her commitment to scientific advancement. Her patent on modified coagulation factor Xa highlights her contributions to the field and showcases her role as a leading inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile